DNA Ginkgo Bioworks Holdings, Inc.: institutional ownership and insider trading
195 funds reported holding $397M of Ginkgo Bioworks Holdings, Inc. in their latest 13F filings; in Q2 2026 funds net bought $42.9M, with 27 new positions and 18 funds selling out; over the last 12 months insiders bought $0 and sold $4.95M on the open market.
Famous investors holding DNA
- Andreas Halvorsen (Viking Global Investors): $35.4M, 0.1% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $5.35M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $6.33M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $2.72M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $1.50M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $599K, 0.0% of the portfolio
Largest institutional holders of DNA
- BlackRock, Inc. (BLK) — $42.4M
- VIKING GLOBAL INVESTORS LP — $35.4M
- Erste Asset Management GmbH — $25.9M
- VANGUARD GROUP INC — $24.1M
- BAILLIE GIFFORD & CO — $23.7M
- VANGUARD CAPITAL MANAGEMENT LLC — $20.7M
- Anchorage Capital Group, L.L.C. — $17.3M
- Legal & General Group Plc — $16.5M
- STATE STREET CORP (STT, STT-PG) — $14.6M
- FORBES J M & CO LLP — $12.5M
Recent DNA insider trades
- Oct 19, 2026: Kelly Jason R sold 45,682 shares ($463K)
- Oct 19, 2026: Shetty Reshma P. sold 41,172 shares ($418K)
- Oct 19, 2026: Canton Barry sold 41,172 shares ($418K)
- Oct 19, 2026: Coen Steven P. sold 766 shares ($7.77K)
5%+ owners
- BlackRock, Inc.: 7.7% (Schedule 13G/A, filed Jul 30, 2026)
- VIKING GLOBAL INVESTORS LP: 7.1% (Schedule 13G/A, filed May 15, 2026)